Melanoma, Cutaneous Malignant: all 135 studies
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous MelanomaActive, not recruitingNCT02385214Not applicable
- Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient OutcomesTerminatedNCT02355587
- 5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay ResultsTerminatedNCT02355574
- MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryCompletedNCT02320305Early Phase 1
- Pancreatic Cancer Screening of High-Risk Individuals in ArkansasWithdrawnNCT02309632Not applicable
- Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic MelanomaCompletedNCT02308553Phase 1/2
- Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant MelanomaStatus unknownNCT02142335Phase 2
- Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By SurgeryCompletedNCT01989559Phase 1
- Efficacy of Propranolol Treatment to Prevent Melanoma ProgressionSuspendedNCT01988831Phase 2
- Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II StudyCompletedNCT01973322Phase 2
- Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by SurgeryTerminatedNCT01940809Phase 1
- Vaccine Therapy in Treating Patients With Advanced Stage III-IV MelanomaTerminatedNCT01744171Phase 1
- Ipilimumab and Imatinib Mesylate in Advanced CancerCompletedNCT01738139Phase 1
- Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma PatientsStatus unknownNCT01729663Phase 2/3
- Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to LiverNo longer availableNCT01728051
- Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerCompletedNCT01727076Phase 1
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsCompletedNCT01522820Phase 1
- A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic MelanomaCompletedNCT01511913
- Comparative Microarray Analysis in Primary Cutaneous Malignant MelanomaCompletedNCT01482260
- Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.Status unknownNCT01168050Phase 2
- Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsCompletedNCT01131234Phase 1
- Ultraviolet Light Exposure and Immunosuppression in Cutaneous MelanomaTerminatedNCT00996827
- Pilot Study of Infrared Imaging of Cutaneous MelanomaCompletedNCT00937690
- A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III MelanomaStatus unknownNCT00925314Phase 2
- Illness Related Distress in Women With Clinically Localized Cutaneous MelanomaCompletedNCT00745862
- Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by SurgeryCompletedNCT00563823Phase 2
- MicroRNA Expression and Function in Cutaneous Malignant MelanomaCompletedNCT00536029
- Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary MelanomaStatus unknownNCT00450593
- Molecular Epidemiology of Cutaneous Malignant MelanomaCompletedNCT00341991
- Genetic Analysis of Familial MelanomaCompletedNCT00339404
- Natural History Study of Moles and Suspicious MelanomaCompletedNCT00288938
- Use of 852A in Metastatic Cutaneous Melanoma.CompletedNCT00189332Phase 2
- Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular MelanomaCompletedNCT00085306Phase 2
- Vaccine Therapy in Treating Patients With Stage IV Cutaneous MelanomaCompletedNCT00074230Phase 1/2